TrialJAMA oncology2020

Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.

Milan Radovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.